YongZhang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer (NCT06670300) | YongZhang | 2024-12-01 |
Track YongZhang automatically
Every clearance here is in the API, with alerts when new ones post.